Antiphospholipid / Hughes Syndrome synonyms

Antiphospholipid syndrome (APS), also widely known as Hughes Syndrome, is an autoimmune disorder characterized by the presence of antiphospholipid antibodies that increase the risk of blood clots. While these names are used interchangeably in clinical practice, the condition is officially classified as Antiphospholipid Syndrome in major medical databases to reflect its underlying pathophysiology.

What are the official and common names for Antiphospholipid / Hughes Syndrome?

In medical literature, you will frequently encounter several terms for the same condition. The most widely accepted clinical term is Antiphospholipid Syndrome (APS), while the eponym Hughes Syndrome is commonly used in honor of Dr. Graham Hughes, who first described the condition in 1983. Because the syndrome involves multiple systems and can present in various ways, it is sometimes referred to as "sticky blood syndrome" in patient-facing literature, though this is a colloquial term rather than a medical diagnosis. Clinically, it may also be categorized as primary APS (when it occurs in isolation) or secondary APS (when it occurs alongside other autoimmune diseases like Systemic Lupus Erythematosus).

Why does Antiphospholipid / Hughes Syndrome have multiple names?

The existence of multiple names for Antiphospholipid / Hughes Syndrome stems from its relatively recent clinical recognition and the evolving understanding of its complex, multisystem nature. Before its formal definition, symptoms were often attributed to other conditions, such as idiopathic thrombosis or lupus-related complications. The name "Hughes Syndrome" persists as a tribute to the physician who identified the link between antiphospholipid antibodies and the clinical symptoms of clotting and pregnancy complications. Today, researchers and clinicians prefer the term Antiphospholipid Syndrome because it accurately describes the immunological mechanism (the presence of antiphospholipid antibodies) that drives the disease process.

How is the condition classified in medical databases?

Standardized medical systems use specific identifiers to ensure consistency in research and clinical records. Understanding these identifiers is helpful when navigating medical documentation for Antiphospholipid / Hughes Syndrome:

• Orphanet: Listed under ORPHA:802 Antiphospholipid syndrome.


• OMIM (Online Mendelian Inheritance in Man): Referenced as #608561 for Antiphospholipid Syndrome.


• ICD-10-CM: Classified under code D68.61 (Antiphospholipid syndrome).


• NIH GARD: Recognizes the condition primarily as Antiphospholipid Syndrome.

Are there regional or historical variations in naming?

While Antiphospholipid / Hughes Syndrome is recognized globally, you may occasionally see older references to "Lupus Anticoagulant Syndrome," a name that originated from the discovery of these antibodies in patients with Systemic Lupus Erythematosus. This term is now considered outdated and potentially misleading, as many individuals with Antiphospholipid / Hughes Syndrome do not have lupus. In international medical settings, "Antiphospholipid syndrome" is the standard nomenclature, ensuring that doctors across different countries communicate clearly about the diagnostic criteria, which currently include the Sapporo criteria and the revised Sydney criteria.

Next steps

• Consult a board-certified rheumatologist or hematologist to confirm your diagnosis and treatment plan.


• Join the community of 451 members at DiseaseMaps.org to share experiences and find support regarding your journey with Antiphospholipid / Hughes Syndrome.


• Keep a digital copy of your laboratory results, specifically testing for lupus anticoagulant, anti-cardiolipin, and anti-beta-2 glycoprotein I antibodies.


• Discuss with your specialist whether you meet the clinical criteria for primary or secondary APS.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Antiphospholipid syndrome (ORPHA:802)


• NIH Genetic and Rare Diseases Information Center (GARD): Antiphospholipid syndrome


• OMIM: Antiphospholipid Syndrome (#608561)


• Hughes Syndrome Foundation: Patient information and research updates